Assessing the unexpected: The unintended consequences of COVID on therapeutics

December 11, 2020
multi-color bubbles

In this Pharmaceutical Executive article, Kristen Backor expands on the results of a CRA study which found that more than half of healthcare providers have changed prescribing decisions in some way as a result of the coronavirus.

As Dr. Backor explains, “These data reflect changes in physician management as a result of the COVID-19 pandemic, and these changes are likely to have an impact into 2021 and beyond.”

Key contacts

Additional contributors